Two PTEN Antibodies Show High Concordance in Breast Cancer Pathology Testing
A retrospective evaluation of 150 breast cancer specimens demonstrated 99.3 percent concordance between SP218 and MXR060 antibodies in detecting PTEN ...
A retrospective evaluation of 150 breast cancer specimens demonstrated 99.3 percent concordance between SP218 and MXR060 antibodies in detecting PTEN ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.